Gene content    
FHIT ( by HUGO)
Fragile Histidine Triad
Tumor suppressor gene
Fragile Histidine Triad
Diadenosine 5'
5'''-P1
P3-Triphosphate Hydrolase
AP3Aase
AP3A Hydrolase
FRA3B
Fragile Histidine Triad Gene
bis(5'-adenosyl)-triphosphatase
dinucleosidetriphosphatase
Tumor Suppressor Protein
Dinucleosidetriphosphatase
EC 3.6.1.29
Fragile Histidine Triad Protein
NCBI: 3p14.2    Ensembl: 3p14.2
FHIT_HUMANSize: 147 amino acidsMass: 16858 Da

  • Subunit: Homodimer. Interacts with UBE2I. Interacts with MDM2. Interacts with CTNNB1. Identified in a complex with CTNNB1 and LEF1 Mass spectrometry: Mass=16733; Method=MALDI; Range=2-147; Source=PubMed:15007172; Selected PDB 3D structures from [IMAGE] and Proteopedia [IMAGE] for FHIT (see all 8): 1FHI (3D) [IMAGE] 1FIT (3D) [IMAGE] 2FHI (3D) [IMAGE] 2FIT (3D) [IMAGE] 3FIT (3D) [IMAGE] 4FIT (3D) [IMAGE]
  • Tissue specificity: Low levels expressed in all tissues tested. Phospho-FHIT observed in liver and kidney, but not in brain and lung. Phospho-FHIT undetected in all tested human tumor cell lines [IMAGE] Pathway & Disease-focused RT2 Profiler PCR Arrays including FHIT: Oncoge
  • Function:
    Cleaves P(1)-P(3)-bis(5'-adenosyl) triphosphate (Ap3A) to yield AMP and ADP. Can also hydrolyze P(1)-P(4)-bis(5'-adenosyl) tetraphosphate (Ap4A), but has extremely low activity with ATP. Modulates transcriptional activation by CTNNB1 and thereby contributes to regulate the expression of genes essential for cell proliferation and survival, such as CCND1 and BIRC5. Plays a role in the induction of apoptosis via SRC and AKT1 signaling pathways. Inhibits MDM2-mediated proteasomal degradation of p53/TP53 and thereby plays a role in p53/TP53-mediated apoptosis. Induction of apoptosis depends on the ability of FHIT to bind P(1)-P(3)-bis(5'-adenosyl) triphosphate or related compounds, but does not require its catalytic activity. Functions as tumor suppressor
                          
    Cleaves P(1)-P(3)-bis(5'-adenosyl) triphosphate (Ap3A) to yield AMP and ADP. Can also hydrolyze P(1)-P(4)-bis(5'-adenosyl) tetraphosphate (Ap4A), but has extremely low activity with ATP. Modulates transcriptional activation by CTNNB1 and thereby contributes to regulate the expression of genes essential for cell proliferation and survival, such as CCND1 and BIRC5. Plays a role in the induction of apoptosis via SRC and AKT1 signaling pathways. Inhibits MDM2-mediated proteasomal degradation of p53/TP53 and thereby plays a role in p53/TP53-mediated apoptosis. Induction of apoptosis depends on the ability of FHIT to bind P(1)-P(3)-bis(5'-adenosyl) triphosphate or related compounds, but does not require its catalytic activity. Functions as tumor suppressor
  • Catalytic activity:
    P(1)-P(3)-bis(5'-adenosyl) triphosphate + H(2)O = ADP + AMP
  • Similarity:
    Contains 1 HIT domain [IMAGE]
  • Protein Domain/Family    
    Source ID Domain Name Type
    InterProIPR001310Histidine_triad_HITHistidine triad (HIT) proteinFamily
    BlocksIPB001310Histidine triad (HIT) proteinHistidine triad (HIT) protein

    Gene Ontology    
    Type Term Evidence Source Pub
    Biological Process negative regulation of proteasomal ubiquitin-dependent protein catabolic process IMP GOA 15313915
    nucleotide metabolic process TAS GOA 8794732
    purine nucleotide metabolic process IDA GOA 9323207
    Cellular Component cytoplasm IDA GOA 15007172
    cytosol IDA GOA 15313915
    Molecular Function bis(5'-adenosyl)-triphosphatase activity IDA GOA 8794732
    catalytic activity TAS GOA 8598045
    hydrolase activity IDA GOA 8794732
    identical protein binding IPI GOA 16189514
    protein binding IPI GOA 18319262
    ubiquitin protein ligase binding IPI GOA 15313915

    Disorder & Mutation    
    Source Disease
    SWISS-PROTNote=A chromosomal aberration involving FHIT has been found in a lymphoblastoid cell line established from a family with renal cell carcinoma and thyroid carcinoma. Translocation t(3;8)(p14.2;q24.1) with RNF139. Although the 3p14.2 breakpoint has been shown to interrupt FHIT in its 5-prime non-coding region, it is unlikely that FHIT is causally related to renal or other malignancies
    SWISS-PROTNote=Associated with digestive tract cancers. Numerous tumor types are found to have aberrant forms of FHIT protein due to deletions in a coding region of chromosome 3p14.2 including the fragile site locus FRA3B

    FHIT cross reference    
    PubMed OMIM Entrez Gene NCKU SNP Nucleotide UniProt Genome Data Viewer HomoloGene